Literature DB >> 16183124

Development of new models for the analysis of Fc-FcRn interactions.

Brian Mohan Gurbaxani1, Sherie L Morrison.   

Abstract

An important question remains as to which FcRn binding parameters, if any, correlate with the serum half-life of antibodies. In the present study, we used a BIACore surface plasmon resonance (SPR) device to study kinetic properties of antibody binding to FcRn at different pHs and under different binding reaction conditions. The ability of many different models to fit the data was tested. The previous models could not adequately explain all of the data collected. We now present models that have intuitive appeal and fit a broader range of data than previous models. Specifically, the model assumes that there are two forms of FcRn on the BIAcore chip and that, in addition to monomeric IgG, there is some aggregated IgG that can function as ligand. Although this model represents an improvement over previous models, it is still not globally valid for the entire range of data that was collected. Even with these limitations, the model provides a powerful new tool to analyze not only FcRn-IgG interactions but also other complex protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183124     DOI: 10.1016/j.molimm.2005.08.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies.

Authors:  Tilman Schlothauer; Petra Rueger; Jan Olaf Stracke; Hubert Hertenberger; Felix Fingas; Lothar Kling; Thomas Emrich; Georg Drabner; Stefan Seeber; Johannes Auer; Stefan Koch; Apollon Papadimitriou
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

Review 2.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 3.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

4.  Characterization and screening of IgG binding to the neonatal Fc receptor.

Authors:  Tobias Neuber; Katrin Frese; Jan Jaehrling; Sebastian Jäger; Daniela Daubert; Karin Felderer; Mechthild Linnemann; Anne Höhne; Stefan Kaden; Johanna Kölln; Thomas Tiller; Bodo Brocks; Ralf Ostendorp; Stefan Pabst
Journal:  MAbs       Date:  2014-04-07       Impact factor: 5.857

5.  Molecular characterization and functional activity of an IL-15 antagonist MutIL-15/Fc human fusion protein.

Authors:  Xiaoyi Yang; Abraham Kallarakal; Nirmala Saptharishi; Hengguang Jiang; Zhiwen Yang; Yueqing Xie; George Mitra; Xin Xiao Zheng; Terry B Strom; Gopalan Soman
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

6.  Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.

Authors:  Nigel M Stapleton; Maximilian Brinkhaus; Kathryn L Armour; Arthur E H Bentlage; Steven W de Taeye; A Robin Temming; Juk Yee Mok; Giso Brasser; Marielle Maas; Wim J E van Esch; Mike R Clark; Lorna M Williamson; C Ellen van der Schoot; Gestur Vidarsson
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.